ETPrime

Jagsonpal Pharmaceuticals Share Price

  • 218.03-1.17 (-0.54%)
  • Volume: 87,733
  • Closed
  • Last Updated On: 14 May, 2025, 03:57 PM IST
STOCK SCORE
ETPrime Only
  • 1D
  • 1W
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Loading...
Jagsonpal Pharmaceuticals Share Price
  • 218.03-1.17 (-0.54%)
  • Volume: 87,733
Advertisment

Jagsonpal Pharm share price insights

View All

  • Company delivered ROE of 23.07% in year ending Mar 31, 2025 outperforming its 5 year avg. of 16.83%. (Source: Standalone Financials)

  • Company witnessed QoQ revenue decline of 19.67%, which is lowest in the last 3 years. (Source: Standalone Financials)

  • Stock gave a 3 year return of 93.84% as compared to Nifty Smallcap 100 which gave a return of 92.16%. (as of last trading session)

  • Company's annual revenue growth of 27.03% outperformed its 3 year CAGR of 6.4%. (Source: Standalone Financials)

  • Jagsonpal Pharmaceuticals Ltd. share price moved down by -0.54% from its previous close of Rs 219.20. Jagsonpal Pharmaceuticals Ltd. stock last traded price is 218.03

    Share PriceValue
    Today/Current/Last218.03
    Previous Day219.20219.10

InsightsJagsonpal Pharm

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Key Metrics

    PE Ratio
    (x)    		26.29
    EPS - TTM
    (₹)    		8.34
    MCap
    (₹ Cr.)    		1,455.46
    Sectoral MCap Rank
    		75
    PB Ratio
    (x)    		6.07
    Div Yield
    (%)    		1.14
    Face Value
    (₹)    		2.00
    Beta

    Beta

    1 Month1.10
    3 Months0.39
    6 Months0.32
    1 Year0.40
    3 Years1.08

    		1.10
    VWAP
    (₹)    		220.32
    52W H/L
    (₹)
    328.04 / 110.00

    Jagsonpal Pharm Share Price Returns

    1 Day-0.54%
    1 Week-0.81%
    1 Month3.47%
    3 Months-5.1%
    1 Year68.1%
    3 Years93.84%
    5 Years2102.32%

    ET Stock ScreenersTop Score Companies

    Check whether Jagsonpal Pharm belongs to analysts' top-rated companies list?

    View Stock Screeners

    Jagsonpal Pharm News & Analysis

    View all Jagsonpal Pharm Share News & Announcements

    Jagsonpal Pharm Share Analysis

    Unlock Stock Score, Analyst' Ratings & Recommendations

    Share Analysis Non Prime User
    • View Stock Score on a 10-point scale
    • See ratings on Earning, Fundamentals, Valuation, Risk & Price
    • Check stock performance
    JOIN ET PRIME

    Jagsonpal Pharm Share Recommendations

    • Target₹47
    • OrganizationNirmal Bang Securities
    • BUY

    That's all for Jagsonpal Pharm recommendations. Check out other stock recos.

    Jagsonpal Pharm Financials

    • Insights

      • Quarterly Topline Performance

        Company witnessed QoQ revenue decline of 19.67%, which is lowest in the last 3 years. (Source: Standalone Financials)

      • Beating 3 Yr Revenue CAGR

        Company's annual revenue growth of 27.03% outperformed its 3 year CAGR of 6.4%. (Source: Standalone Financials)
      Quarterly | AnnualMar 2025Dec 2024Sep 2024Jun 2024Mar 2024
      Total Income61.3376.3576.3562.8845.97
      Total Income Growth (%)-19.670.0021.4136.78-7.60
      Total Expenses52.3637.4260.7555.5641.22
      Total Expenses Growth (%)39.93-38.409.3434.78-6.85
      EBIT8.9738.9315.607.334.75
      EBIT Growth (%)-76.96149.56112.9454.11-13.66
      Profit after Tax (PAT)6.5831.9911.465.333.55
      PAT Growth (%)-79.42179.17115.0350.15-10.45
      EBIT Margin (%)14.6250.9920.4311.6510.34
      Net Profit Margin (%)10.7341.9015.018.477.72
      Basic EPS (₹)0.9812.094.291.941.31
      Quarterly | Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Total Revenue276.91217.98242.45229.43192.34
      Total Revenue Growth (%)27.03-10.095.6719.2919.40
      Total Expenses226.73188.11204.18202.11170.47
      Total Expenses Growth (%)20.53-7.871.0218.5612.39
      Profit after Tax (PAT)55.3622.4626.7219.5917.06
      PAT Growth (%)146.45-15.9436.4214.82116.73
      Operating Profit Margin (%)19.0214.7016.3412.2012.21
      Net Profit Margin (%)20.6010.7611.288.669.07
      Basic EPS (₹)8.268.4910.207.486.51

      All figures in Rs Cr, unless mentioned otherwise

      View Details

      No reported Profit & Loss Statement are available.

    • Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Total Assets278.26217.08194.95168.45164.20
      Total Assets Growth (%)28.1811.3515.732.5911.74
      Total Liabilities38.3129.6836.0637.6042.27
      Total Liabilities Growth (%)29.08-17.69-4.10-11.0517.68
      Total Equity239.95187.40158.89130.86121.93
      Total Equity Growth (%)28.0417.9421.427.329.82
      Current Ratio (x)6.2210.425.973.242.98
      Total Debt to Equity (x)0.000.000.000.000.06
      Contingent Liabilities0.0011.226.095.875.99

      All figures in Rs Cr, unless mentioned otherwise

      View Details

      No reported Balance Sheet are available.

    • Insights

      • Increase in Cash from Investing

        Company has used Rs 45.15 cr for investing activities which is an YoY increase of 83.91%. (Source: Standalone Financials)
      Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Net Cash flow from Operating Activities55.3035.1746.665.6028.22
      Net Cash used in Investing Activities-45.15-24.55-57.67-26.21-2.26
      Net Cash flow from Financing Activities-11.70-8.91-0.46-12.30-6.83
      Net Cash Flow-1.551.71-11.47-32.9119.13
      Closing Cash & Cash Equivalent11.2212.7611.0526.0358.94
      Closing Cash & Cash Equivalent Growth (%)-12.1115.44-57.54-55.8454.81
      Total Debt/ CFO (x)0.000.000.000.000.24

      All figures in Rs Cr, unless mentioned otherwise

      View Details

      No reported Cash Flow Statement are available.

    • Insights

      • ROE Outperforming 5 Year Average

        Company delivered ROE of 23.07% in year ending Mar 31, 2025 outperforming its 5 year avg. of 16.83%. (Source: Standalone Financials)
      Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Return on Equity (%)23.0711.9816.8115.9214.95
      Return on Capital Employed (%)20.2615.5023.1020.5518.54
      Return on Assets (%)19.8910.3413.7011.6210.38
      Interest Coverage Ratio (x)61.8639.7496.57102.1821.14
      Asset Turnover Ratio (x)1.081.011.301.36114.45
      Price to Earnings (x)25.9133.0028.4942.0212.22
      Price to Book (x)5.983.954.786.681.83
      EV/EBITDA (x)22.0218.3016.1727.316.60
      EBITDA Margin (%)22.0515.4916.8412.8812.48

      No reported Financial Ratios are available.

    Financial InsightsJagsonpal Pharm

    • Income (P&L)
    • Cash Flow
    • Ratios

      • Quarterly Topline Performance

        Company witnessed QoQ revenue decline of 19.67%, which is lowest in the last 3 years. (Source: Standalone Financials)

      • Beating 3 Yr Revenue CAGR

        Company's annual revenue growth of 27.03% outperformed its 3 year CAGR of 6.4%. (Source: Standalone Financials)

      • Increase in Cash from Investing

        Company has used Rs 45.15 cr for investing activities which is an YoY increase of 83.91%. (Source: Standalone Financials)

      • ROE Outperforming 5 Year Average

        Company delivered ROE of 23.07% in year ending Mar 31, 2025 outperforming its 5 year avg. of 16.83%. (Source: Standalone Financials)

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Jagsonpal Pharm Technicals

    • Stock doesn't have any Buy/Sell Signals.

    • Price Analysis Data details are not available.

    • Pivot Levels

      R1R2R3PIVOTS1S2S3
      Classic-------

      Average True Range

      5 DAYS14 DAYS28 DAYS
      ATR---

    Jagsonpal Pharm Peer Comparison

      • CHART
      • TABLE

      Insights

      • Stock Returns vs Nifty Smallcap 100

        Stock gave a 3 year return of 93.84% as compared to Nifty Smallcap 100 which gave a return of 92.16%. (as of last trading session)

      • Stock Returns vs Nifty Pharma

        Stock generated 93.84% return as compared to Nifty Pharma which gave investors 69.13% return over 3 year time period. (as of last trading session)

      • Choose from Peers

          Choose from Stocks

          • 1D
          • 1W
          • 1M
          • 3M
          • 6M
          • 1Y
          • 5Y
          Loading...

        • Insights

          • Stock Returns vs Nifty Smallcap 100

            Stock gave a 3 year return of 93.84% as compared to Nifty Smallcap 100 which gave a return of 92.16%. (as of last trading session)

          • Stock Returns vs Nifty Pharma

            Stock generated 93.84% return as compared to Nifty Pharma which gave investors 69.13% return over 3 year time period. (as of last trading session)

          Ratio Performance

          NAMEP/E (x)P/B (x)ROE %ROCE %ROA %Rev CAGR [3Yr]OPMNPMBasic EPSCurrent RatioTotal Debt/ Equity (x)Total Debt/ CFO (x)
          Jagsonpal Pharm26.296.0723.0720.2619.896.4019.0220.608.266.220.000.00
          Solara Active Pharma-10.462.82-60.75-17.42-24.13-7.62-14.98-43.98-157.620.641.079.18
          SMS Pharma34.074.209.2912.754.817.9112.626.935.891.620.525.59
          Amrutanjan Health Care41.627.1115.5820.9112.258.2514.7410.6715.504.230.000.00
          IOL Chemicals20.051.218.3411.745.982.779.276.3022.902.000.000.00
          Add More
          Annual Ratios (%)

          Choose from Peers

          • Bajaj Healthcare
          • Syncom Form
          • Bliss GVS Pharma
          • Themis Medicare
          • Lincoln Pharma

          Choose from Stocks

            See All Parameters

          Peers InsightsJagsonpal Pharm

          • Stock Returns vs Nifty Smallcap 100

            Stock gave a 3 year return of 93.84% as compared to Nifty Smallcap 100 which gave a return of 92.16%. (as of last trading session)

          • Stock Returns vs Nifty Pharma

            Stock generated 93.84% return as compared to Nifty Pharma which gave investors 69.13% return over 3 year time period. (as of last trading session)

          Do you find these insights useful?

          • hate it

          • meh

          • love it

          Jagsonpal Pharm Shareholding Pattern

          • Loading...
            Showing Jagsonpal Pharm Shareholding as on Mar 2025
            CategoryMar 2025Dec 2024Sep 2024Jun 2024
            Promoters67.7867.8167.9768.04
            Pledge0.000.000.000.00
            FII2.102.102.301.10
            DII0.000.000.110.84
            Mutual Funds0.000.000.110.00
            Others30.1230.0929.6230.01
          • Showing Shareholding as on Mar 2025
            CategoryNo. of SharesPercentage% Change QoQ
            Promoters4,50,04,78567.78 %-0.03
            Pledge00.00 %0.00
            FII13,96,7982.10 %0.00
            DII29,5680.11 %-0.73
            MF29,5680.11 %0.11
            Others1,99,67,47930.12 %0.03

          Jagsonpal Pharm MF Ownership

          MF Ownership details are not available.

          Top Searches:
          Jagsonpal Pharm News Jagsonpal Pharm Quarterly Results Jagsonpal Pharm Dividend Jagsonpal Pharm Q1 ResultsJagsonpal Pharm Q2 ResultsJagsonpal Pharm Q3 ResultsJagsonpal Pharm Q4 Results

          Jagsonpal Pharm Corporate Actions

          • Meeting DateAnnounced onPurposeDetails
            May 06, 2025Apr 29, 2025Board MeetingAudited Results & Final Dividend
            Jan 22, 2025Jan 15, 2025Board MeetingQuarterly Results
            Dec 13, 2024Nov 11, 2024POM-
            Oct 23, 2024Oct 16, 2024Board MeetingQuarterly Results & Stock Split
            Sep 18, 2024Aug 07, 2024AGM-
          • TypeDividendDividend per ShareEx-Dividend DateAnnounced on
            Final100%5.0Sep 06, 2024May 21, 2024
            Final100%5.0Aug 21, 2023May 23, 2023
            Interim80%4.0Oct 29, 2021Oct 19, 2021
            Final20%1.0Sep 22, 2021Jun 30, 2021
            Final125%2.5-May 06, 2025
          • All TypesEx-DateRecord DateAnnounced onDetails
            SplitsJan 08, 2025Jan 08, 2025Oct 23, 2024Split: Old FV5.0| New FV:2.0
            SplitsJul 20, 2004Jul 28, 2004Apr 30, 2004Split: Old FV10.0| New FV:5.0
            BonusJul 20, 2004Jul 28, 2004Apr 30, 2004Bonus Ratio: 3 share(s) for every 1 shares held

          About Jagsonpal Pharm

          Jagsonpal Pharmaceuticals Ltd., incorporated in the year 1978, is a Small Cap company (having a market cap of Rs 1,455.46 Crore) operating in Pharmaceuticals sector. Jagsonpal Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals for the year ending 31-Mar-2024. Show More

          • Executives

          • Auditors

          • RS

            Rajpal Singh Kochhar

            Chairman Emeritus
            HR

            Harsha Raghavan

            Chairman & Non-Exe.Director
            MG

            Manish Gupta

            Managing Director
            PS

            Prithipal Singh Kochhar

            Non Executive Director
            Show More
          • Walker Chandiok & Co. LLP
            H L Bansal & Co.

          Industry

          Pharma - Indian

          Key Indices Listed on

          -

          Address

          T-210 J, Shahpur Jat,New Delhi, Delhi - 110049

          Contact

          [email protected]

          http://www.jagsonpal.com

          More Details

          FAQs about Jagsonpal Pharm share

          • 1. What's Jagsonpal Pharm share price today and what are Jagsonpal Pharm share returns ?
            Jagsonpal Pharm share price is Rs 218.03 as on 14 May, 2025, 03:55 PM IST. Jagsonpal Pharm share price is down by 0.54% based on previous share price of Rs 222.03. Jagsonpal Pharm share price trend:
            • Last 3 Months: Jagsonpal Pharm share price moved down by 5.10%
            • Last 12 Months: Jagsonpal Pharm share price moved up 68.10%
            • Last 3 Years: Jagsonpal Pharm Share price moved up by 93.84%
          • 2. What is the market cap of Jagsonpal Pharm?
            Jagsonpal Pharm share has a market capitalization of Rs 1,455.46 Cr. Within Pharmaceuticals sector, it's market cap rank is 75.
          • 3. What are the Jagsonpal Pharm quarterly results?
            On Standalone basis, Jagsonpal Pharm reported a total income and loss of Rs 61.33 Cr and Rs 6.58 respectively for quarter ending resultQuarterlyResult.list[0].yearEnding. Total Income and profit for the year ending 2025-03-31 was Rs 276.91 Cr and Rs 55.36 Cr.
          • 4. What are the returns for Jagsonpal Pharm share?
            Return Performance of Jagsonpal Pharm Shares:
            • 1 Week: Jagsonpal Pharm share price moved down by 0.81%
            • 3 Month: Jagsonpal Pharm share price moved down by 5.10%
            • 6 Month: Jagsonpal Pharm share price moved up by 2.17%
          • 5. What dividend is Jagsonpal Pharm giving?
            Jagsonpal Pharmaceuticals Ltd. announced an equity dividend of 100% on a face value of 2.0 amounting to Rs 5 per share on 21 May 2024. The ex dividend date was 06 Sep 2024.
          • 6. What is the CAGR of Jagsonpal Pharm?
            The CAGR of Jagsonpal Pharm is 4.41.
          • 7. Who's the chairman of Jagsonpal Pharm?
            Rajpal Singh Kochhar is the Chairman Emeritus of Jagsonpal Pharm
          • 8. What is Jagsonpal Pharm's 52 week high / low?
            52 Week high of Jagsonpal Pharm share is Rs 328.04 while 52 week low is Rs 110.00
          • 9. What are the key metrics to analyse Jagsonpal Pharm Share Price?
            Jagsonpal Pharm share can be quickly analyzed on following metrics:
            • Stock's PE is 26.29
            • Price to Book Ratio of 6.07
          • 10. Which are the key peers to Jagsonpal Pharm?
            Top 10 Peers for Jagsonpal Pharm are SMS Pharmaceuticals Ltd., Syncom Formulation (India) Ltd., Amrutanjan Health Care Ltd., Bliss GVS Pharma Ltd., Lincoln Pharmaceuticals Ltd., Themis Medicare Ltd., Solara Active Pharma Sciences Ltd., Bajaj Healthcare Ltd., IOL Chemicals and Pharmaceuticals Ltd. and NGL Fine - Chem Ltd.
          • 11. Who owns Jagsonpal Pharm?
              • Promoter holding have gone down from 68.04 (30 Jun 2024) to 67.78 (31 Mar 2025)
              • Domestic Institutional Investors holding have gone down from 0.82 (31 Dec 2023) to 0.11 (30 Sep 2024)
              • Foreign Institutional Investors holding has gone up from 1.1 (30 Jun 2024) to 2.1 (31 Mar 2025)
              • Other investor holding has gone up from 30.01 (30 Jun 2024) to 30.12 (31 Mar 2025)
          • 12. What is the PE & PB ratio of Jagsonpal Pharm?
            The PE ratio of Jagsonpal Pharm stands at 26.29, while the PB ratio is 6.07.

          Trending in Markets

          Top Gainers As on 04:11 PM | 14 May 2025

          GRSE2,188.00
          273.21 (14.27%)
          HBL Power569.05
          62.50 (12.34%)
          Authum Investment2,135.60
          200.10 (10.34%)
          PTC Industries14,005.00
          1253.00 (9.83%)
          Railtel Corp356.55
          30.70 (9.43%)

          Top Losers As on 03:59 PM | 14 May 2025

          Raymond551.20
          -1013.10 (-64.77%)
          Syrma SGS Technology526.00
          -38.40 (-6.81%)
          Metropolis Health1,614.50
          -87.10 (-5.12%)
          Vijaya Diagnostic931.10
          -39.00 (-4.03%)
          REC389.50
          -12.25 (-3.05%)

          DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

          DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

          By using this site, you agree to the Terms of Service and Privacy Policy.

          Business News›Markets›Stocks›Stock Price Quotes›Jagsonpal Pharm Share Price
          The Economic Times
          BrowseCompanies:
          OSZAR »